borderline significancep = 0.053
At baseline, the proportion of patients experiencing certain comorbidities was not significantly different between those who received a CMV diagnosis during follow-up and those who did not, with borderline significance for hemorrhagic conditions in SOT patients (23.8 vs. 12.0%, p = 0.053) and dorsalgia in allo-HSCT recipients (53.0 vs. 38.8%, p = 0.055).